|
|
CytonomeST Announces New CEO
Boston, MA, March 1, 2009- CytonomeST, LLC. today announced that Dr. John Sharpe has been appointed Chief Executive Officer. Dr. Sharpe was a former Director of Photara Technologies, a Business Manager for Dexcel N.Z, and a Director of R&D for DakoCytomation with project management responsibilities for developing laser-based cell sorting technology. Dr. Sharpe holds a Ph.D. from Waikato University .
About CytonomeST
CytonomeST. develops, manufactures and markets clinical grade optical cell sorting systems. CytonomeST's Gigasort™ system is the only clinical-grade optical cell sorter that uses a sterile, disposable cartridge for precise and safe selection of discrete cell populations. Gigasort systems are designed to enable novel cellular therapies to move from laboratory to clinical trials and into scalable commercial manufacturing. Gigasort systems enable cell based therapy applications in oncology, autoimmune disease, tissue regeneration and tissue engineering.
|
